Literature DB >> 19551406

DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells.

Shuang Bing Xu1, Xiao Hong Liu, Ben Hui Li, Yan Zhang, Jia Yuan, Qin Yuan, Pin Dong Li, Xian Zi Yang, Feng Li, Wen Jie Zhang.   

Abstract

PURPOSE: Stat6 signaling is active in cancer cells and IL-4-induced Stat6 activities or Stat6 activational phenotypes vary among cancer cells. This study aimed at investigating possible mechanism(s) involved in the formation of varying Stat6 activities/phenotypes.
METHODS: Stat6 regulatory genes, SOCS-1 and SHP-1, were examined for mRNA expression using RT-PCR, and their promoter DNA methylation was assayed by methylation-specific PCR in Stat6-phenotyped colon cancer cell lines. DNA methylation was then verified by sequencing. RT-PCR assay and Western blotting were used to detect the expression of SOCS-1 and SHP-1 after demethylation using 5-aza-2'-deoxycytidine.
RESULTS: Compared with Stat6(null) Caco-2 cells, Stat6(high) HT-29 cells showed decreased constitutive expression of SOCS-1 and SHP-1, which correlated with DNA hypermethylation in these genes' promoters. Interestingly, demethylation in HT-29 cells recovered the constitutive expression of SOCS-1 and SHP-1.
CONCLUSIONS: These findings suggest that DNA methylation controls the constitutive expression of negative Stat6 regulatory genes, which may affect Stat6 activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551406     DOI: 10.1007/s00432-009-0627-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  36 in total

1.  DNA methylation and epigenetic mechanisms of carcinogenesis.

Authors:  S Baylin
Journal:  Dev Biol (Basel)       Date:  2001

Review 2.  Detection and interpretation of altered methylation patterns in cancer cells.

Authors:  Toshikazu Ushijima
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

Review 3.  Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).

Authors:  Richard L Momparler
Journal:  Semin Oncol       Date:  2005-10       Impact factor: 4.929

Review 4.  JAK/STAT signal transduction: regulators and implication in hematological malignancies.

Authors:  Lyne Valentino; Josiane Pierre
Journal:  Biochem Pharmacol       Date:  2006-01-19       Impact factor: 5.858

5.  STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells.

Authors:  Mingsheng Zhang; Yunfeng Zhou; Conghua Xie; Fuxiang Zhou; Yun Chen; Guang Han; Wen Jie Zhang
Journal:  Cancer Lett       Date:  2006-01-04       Impact factor: 8.679

Review 6.  Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha; Virginia Clements; Samudra I Dissanayake; Seth Miller; Cordula Davis; Erika Danna
Journal:  Cancer Immunol Immunother       Date:  2003-10-30       Impact factor: 6.968

7.  Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.

Authors:  Yasuhiro Oshimo; Kazuya Kuraoka; Hirofumi Nakayama; Yasuhiko Kitadai; Kazuhiro Yoshida; Kazuaki Chayama; Wataru Yasui
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

Review 8.  DNA methylation as a therapeutic target in cancer.

Authors:  Jean-Pierre J Issa
Journal:  Clin Cancer Res       Date:  2007-03-15       Impact factor: 12.531

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 10.  Epigenetic changes in cancer.

Authors:  Kirsten Grønbaek; Christoffer Hother; Peter A Jones
Journal:  APMIS       Date:  2007-10       Impact factor: 3.205

View more
  10 in total

1.  Extensive survey of STAT6 expression in a large series of mesenchymal tumors.

Authors:  Elizabeth G Demicco; Paul W Harms; Rajiv M Patel; Steven C Smith; Davis Ingram; Keila Torres; Shannon L Carskadon; Sandra Camelo-Piragua; Jonathan B McHugh; Javed Siddiqui; Nallasivam Palanisamy; David R Lucas; Alexander J Lazar; Wei-Lien Wang
Journal:  Am J Clin Pathol       Date:  2015-05       Impact factor: 2.493

2.  Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease.

Authors:  George P Christophi; Rong Rong; Philip G Holtzapple; Paul T Massa; Steve K Landas
Journal:  Inflamm Bowel Dis       Date:  2012-03-29       Impact factor: 5.325

3.  Effects of Herba epimedii and Fructus ligustri lucidi on the transcription factors in hypothalamus of aged rats.

Authors:  Jing Cai; Teng Zheng; Lei Zhang; Yun Tian; Min-he Yang; Jian Du
Journal:  Chin J Integr Med       Date:  2011-03-30       Impact factor: 1.978

4.  PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas.

Authors:  Linda Sooman; Simon Ekman; Georgios Tsakonas; Archita Jaiswal; Sanjay Navani; Per-Henrik Edqvist; Fredrik Pontén; Stefan Bergström; Mikael Johansson; Xuping Wu; Erik Blomquist; Michael Bergqvist; Joachim Gullbo; Johan Lennartsson
Journal:  Tumour Biol       Date:  2014-02-09

5.  Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival.

Authors:  Chong Wang; Caixia Zhu; Fang Wei; Liming Zhang; Xiaohui Mo; Yanling Feng; Jianqing Xu; Zhenghong Yuan; Erle Robertson; Qiliang Cai
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

6.  The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.

Authors:  Alessia Varone; Chiara Amoruso; Marcello Monti; Manpreet Patheja; Adelaide Greco; Luigi Auletta; Antonella Zannetti; Daniela Corda
Journal:  Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.712

Review 7.  The role of suppressors of cytokine signalling in human neoplasms.

Authors:  Walid Sasi; Anup K Sharma; Kefah Mokbel
Journal:  Mol Biol Int       Date:  2014-03-16

8.  Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.

Authors:  Sylvie Dunoyer-Geindre; Anne-Sophie Rivier-Cordey; Carlos Caetano; Richard J Fish; Egbert K O Kruithof
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

9.  Role and mechanism of decitabine combined with tyrosine kinase inhibitors in advanced chronic myeloid leukemia cells.

Authors:  Li-Cai Jiang; Jian-Min Luo
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

Review 10.  SHP-1: the next checkpoint target for cancer immunotherapy?

Authors:  H Angharad Watson; Sophie Wehenkel; James Matthews; Ann Ager
Journal:  Biochem Soc Trans       Date:  2016-04-15       Impact factor: 5.407

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.